Despite significant changes to the Matthews India management team in recent years, the strategy remains in the hands of a capable portfolio manager. However, broader turnover across the investment teams, including India-focused analysts, introduces some uncertainty around the depth of research support and the consistency of process execution. As a result, we have downgraded the Process Pillar to Average from Above Average while maintaining its Average People Pillar rating.
Matthews India Fund Investor Class MINDX
- NAV / 1-Day Return 21.64 / −0.14 %
- Total Assets 480.1M
-
Adj. Expense Ratio
1.260%
- Expense Ratio 1.260%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category India Equity
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.03%
- Turnover 54%
USD | NAV as of Jun 18, 2026 | 1-Day Return as of Jun 18, 2026, 12:41 AM GMT+0
Morningstar’s Analysis MINDX
Will MINDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the MINDX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of MINDX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 45.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
HDFC Bank Ltd | 7.65 | 38M | Financial Services |
Eternal Ltd | 6.59 | 32M | Consumer Cyclical |
ICICI Bank Ltd | 5.45 | 27M | Financial Services |
Reliance Industries Ltd | 5.16 | 25M | Energy |
Bharti Airtel Ltd | 4.11 | 20M | Communication Services |
Shriram Finance Ltd | 3.56 | 17M | Financial Services |
State Bank of India | 3.53 | 17M | Financial Services |
Bajaj Finance Ltd | 3.35 | 16M | Financial Services |
Infosys Ltd | 3.22 | 16M | Technology |
Neuland Laboratories Ltd | 2.89 | 14M | Healthcare |
United States